| Attribute |
Value |
| 52 Week Change |
-0.094202876 |
| Address1 |
12,100 West Sixth Avenue |
| All Time High |
333.42 |
| All Time Low |
0.25 |
| Ask |
130.12 |
| Ask Size |
2 |
| Audit Risk |
8 |
| Average Daily Volume10 Day |
103,560 |
| Average Daily Volume3 Month |
108,763 |
| Average Volume |
108,763 |
| Average Volume10Days |
103,560 |
| Beta |
0.894 |
| Bid |
74.31 |
| Bid Size |
2 |
| Board Risk |
4 |
| Book Value |
33.791 |
| City |
Lakewood |
| Compensation Risk |
2 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
101.99 |
| Current Ratio |
1.942 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
103.805 |
| Day Low |
100.6 |
| Debt To Equity |
91.069 |
| Display Name |
Mesa Laboratories |
| Dividend Date |
1,773,619,200 |
| Dividend Rate |
0.64 |
| Dividend Yield |
0.65 |
| Earnings Timestamp |
1,770,125,400 |
| Earnings Timestamp End |
1,779,971,400 |
| Earnings Timestamp Start |
1,779,971,400 |
| Ebitda |
42,250,000 |
| Ebitda Margins |
0.17068 |
| Enterprise To Ebitda |
16.216 |
| Enterprise To Revenue |
2.768 |
| Enterprise Value |
685,123,264 |
| Eps Current Year |
7.35 |
| Eps Forward |
5.39 |
| Eps Trailing Twelve Months |
0.65 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,780,012,800 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
89.1144 |
| Fifty Day Average Change |
12.875595 |
| Fifty Day Average Change Percent |
0.14448388 |
| Fifty Two Week Change Percent |
-9.420288 |
| Fifty Two Week High |
131.2 |
| Fifty Two Week High Change |
-29.21 |
| Fifty Two Week High Change Percent |
-0.22263719 |
| Fifty Two Week Low |
55.45 |
| Fifty Two Week Low Change |
46.539997 |
| Fifty Two Week Low Change Percent |
0.83931464 |
| Fifty Two Week Range |
55.45 - 131.2 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
446,913,000,000 |
| Five Year Avg Dividend Yield |
0.5 |
| Float Shares |
5,034,928 |
| Forward Eps |
5.39 |
| Forward P E |
18.922077 |
| Free Cashflow |
36,833,624 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
730 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,775,001,600 |
| Gross Margins |
0.62404996 |
| Gross Profits |
154,476,992 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.05435 |
| Held Percent Institutions |
0.95723 |
| Implied Shares Outstanding |
5,524,813 |
| Industry |
Scientific & Technical Instruments |
| Industry Disp |
Scientific & Technical Instruments |
| Industry Key |
scientific-technical-instruments |
| Ir Website |
http://www.mesalabs.com/corporate/investor.html |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,772,150,400 |
| Last Dividend Value |
0.16 |
| Last Fiscal Year End |
1,743,379,200 |
| Long Business Summary |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado. |
| Long Name |
Mesa Laboratories, Inc. |
| Market |
us_market |
| Market Cap |
563,475,648 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_287550 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
3,734,000 |
| Next Fiscal Year End |
1,774,915,200 |
| Non Diluted Market Cap |
545,575,283 |
| Number Of Analyst Opinions |
2 |
| Open |
100.6 |
| Operating Cashflow |
41,534,000 |
| Operating Margins |
0.12245 |
| Overall Risk |
3 |
| Payout Ratio |
0.9846 |
| Phone |
303 987 8000 |
| Previous Close |
98.75 |
| Price Eps Current Year |
13.87619 |
| Price Hint |
2 |
| Price To Book |
3.0182593 |
| Price To Sales Trailing12 Months |
2.2762923 |
| Profit Margins |
0.01508 |
| Quick Ratio |
1.3 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
3.2399979 |
| Regular Market Change Percent |
3.2810104 |
| Regular Market Day High |
103.805 |
| Regular Market Day Low |
100.6 |
| Regular Market Day Range |
100.6 - 103.805 |
| Regular Market Open |
100.6 |
| Regular Market Previous Close |
98.75 |
| Regular Market Price |
101.99 |
| Regular Market Time |
1,776,450,140 |
| Regular Market Volume |
74,010 |
| Return On Assets |
0.0247 |
| Return On Equity |
0.02184 |
| Revenue Growth |
0.036 |
| Revenue Per Share |
45.096 |
| Sand P52 Week Change |
0.36506534 |
| Sector |
Technology |
| Sector Disp |
Technology |
| Sector Key |
technology |
| Share Holder Rights Risk |
3 |
| Shares Outstanding |
5,524,813 |
| Shares Percent Shares Out |
0.04 |
| Shares Short |
220,739 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
223,687 |
| Short Name |
Mesa Laboratories, Inc. |
| Short Percent Of Float |
0.0582 |
| Short Ratio |
1.64 |
| Source Interval |
15 |
| State |
CO |
| Symbol |
MLAB |
| Target High Price |
115.0 |
| Target Low Price |
94.0 |
| Target Mean Price |
104.5 |
| Target Median Price |
104.5 |
| Total Cash |
30,470,000 |
| Total Cash Per Share |
5.515 |
| Total Debt |
170,018,000 |
| Total Revenue |
247,540,992 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.64 |
| Trailing Annual Dividend Yield |
0.0064810123 |
| Trailing Eps |
0.65 |
| Trailing P E |
156.9077 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
78.87855 |
| Two Hundred Day Average Change |
23.11145 |
| Two Hundred Day Average Change Percent |
0.29300046 |
| Type Disp |
Equity |
| Volume |
74,010 |
| Website |
https://www.mesalabs.com |
| Zip |
80,228 |